 |
|
Hepatitis B Vaccination and Hepatocellular Carcinoma Rates in Boys and Girls
Mei-Hwei Chang, MD;
Wen-Yi Shau, MD, PhD;
Chien-Jen Chen, ScD;
Tzee-Chung Wu, MD;
Man-Shan Kong;
Der-Cherng Liang, MD;
Hsu-Mei Hsu, MPH;
Huey-Ling Chen, MD;
Hong-Yuan Hsu, MD, PhD;
Ding-Shinn Chen, MD;
for the Taiwan Childhood Hepatoma Study Group
JAMA. 2000;284:3040-3042.
Context Hepatocellular carcinoma (HCC) has a male predominance and is closely related to hepatitis B virus (HBV) infection. Hepatitis B virus vaccination was launched in 1984 in Taiwan for neonates of mothers carrying hepatitis B e antigen, resulting in a decreased incidence of HCC in children. The effect on boys vs girls is not known.
Objective To evaluate the association between a HBV vaccination program with incidence of childhood HCC by sex.
Design and Setting Analysis of data collected from Taiwan's National Cancer Registry System and the Taiwan Childhood Hepatoma Study Group between 1981 and 1996.
Participants Children aged 6 to 14 years who were diagnosed as having HCC (201 boys and 70 girls).
Main Outcome Measure Incidence of HCC in boys and girls before and after implementation of the vaccination program.
Results The boy-girl incidence ratio decreased steadily from 4.5 in 1981-1984 (before the program's introduction) to 1.9 in 1990-1996 (6-12 years after the vaccination program was launched). The incidence of HCC in boys born after 1984 was significantly reduced in comparison with those born before 1978 (relative risk [RR], 0.72; P = .002). No significant decrease in HCC incidence was observed in girls born in the same periods (RR, 0.77; P = .20). The incidence of HCC in boys remained stable with increasing age, while an increase of HCC incidence with age in girls was observed. These age and sex effects remained the same regardless of birth before or after the vaccination program.
Conclusion Our results suggest that boys may benefit more from HBV vaccination than girls in the prevention of HCC.
Author Affiliations: Department of Pediatrics (Drs Chang, H. Y. Hsu, and H. L. Chen) and Hepatitis Research Center (Dr D. S. Chen), National Taiwan University Hospital, Taipei; Graduate Institute of Clinical Medicine, College of Medicine (Dr Shau) and Graduate Institute of Epidemiology, College of Public Health (Dr C. J. Chen), National Taiwan University, Taipei, Department of Pediatrics, Veteran General Hospital, Taipei (Dr Wu); Chang-Gung Children's Hospital, Lin-Kou (Mr Kong); Department of Pediatrics, Mackay Memorial Hospital, Taipei (Dr Liang); and Center for Disease Control, Department of Health, Executive Yuan (Dr H. M. Hsu), Taipei, Taiwan, Republic of China.
RELATED ARTICLE
December 20, 2000
JAMA. 2000;284(23):3067-3068.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Increased Childhood Liver Cancer Mortality and Arsenic in Drinking Water in Northern Chile
Liaw et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1982-1987.
ABSTRACT
| FULL TEXT
Profile of Ding-Shinn Chen
Downey
Proc. Natl. Acad. Sci. USA 2007;104:15173-15175.
FULL TEXT
Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa
Kirk et al.
Carcinogenesis 2006;27:2070-2082.
ABSTRACT
| FULL TEXT
Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched
Chien et al.
Epidemiol Rev 2006;28:126-135.
ABSTRACT
| FULL TEXT
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward
Kelloff et al.
Clin. Cancer Res. 2006;12:3661-3697.
ABSTRACT
| FULL TEXT
Hepatitis B -- Preventable and Now Treatable
Hoofnagle
NEJM 2006;354:1074-1076.
FULL TEXT
Hepatitis vaccines
Karayiannis et al.
Br Med Bull 2004;70:29-49.
FULL TEXT
Trends in the Incidence of Hepatocellular Carcinoma in Boys and Girls in Taiwan after Large-Scale Hepatitis B Vaccination
Lee et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:57-59.
ABSTRACT
| FULL TEXT
Hepatitis B, Gender, and Hepatocellular Cancer
JWatch Infect. Diseases 2001;2001:10-10.
FULL TEXT
|
